1. Home
  2. LMAT

as 12-20-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Founded: 1983 Country:
United States
United States
Employees: N/A City: BURLINGTON
Market Cap: 2.4B IPO Year: 2006
Target Price: $92.83 AVG Volume (30 days): 216.4K
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield:
0.69%
Dividend Payout Frequency: Quarterly
EPS: 1.82 EPS Growth: 49.21
52 Week Low/High: $52.88 - $109.58 Next Earning Date: 10-31-2024
Revenue: $213,029,000 Revenue Growth: 14.81%
Revenue Growth (this year): 16.04% Revenue Growth (next year): 9.62%

LMAT Daily Stock ML Predictions

Stock Insider Trading Activity of LeMaitre Vascular Inc. (LMAT)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Jasinski Lawrence J LMAT Director Nov 20 '24 Sell $103.50 198 $20,493.00 5,111
Ross Bridget A LMAT Director Nov 15 '24 Sell $101.47 3,750 $380,512.50 2,278
SHADAN MARTHA LMAT Director Nov 13 '24 Sell $103.38 1,466 $151,547.27 1,700

Share on Social Networks: